Michael Douglass Rees - 11 Sep 2026 Form 4 Insider Report for BLUE OWL CAPITAL INC. (OWL)

Reporting relationship: Co-President, Director
Issuer ticker: OWL
Reported as of: 11 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Sep 2026, 16:30:03 UTC
Prior SEC filing: 07 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Neena A. Reddy, as Attorney-in-Fact

Filing notes and source

Key filing fact

Michael Douglass Rees filed Form 4 for BLUE OWL CAPITAL INC. (OWL) on 11 Sep 2026.

Key facts

This page summarizes Michael Douglass Rees's Form 4 filing for BLUE OWL CAPITAL INC. (OWL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Sep 2026, 16:30.

Change

Previous filing in this sequence was filed on 07 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001861792 Primary reporting owner

Rees Michael Douglass

Relationship: Co-President, Director
Address: 399 PARK AVENUE, 37TH FLOOR, NEW YORK
Signature: /s/ Neena A. Reddy, as Attorney-in-Fact
Signature date: 11 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OWL transaction

Class D Shares

Gift

Transaction value
Shares: -300,000
Change %: -2.7%
Price
Shares after: 10,909,723
Date: 11 Sep 2026
Ownership: See Footnotes
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OWL transaction Derivative

Blue Owl Operating Group Units

Gift

Transaction value
Shares: -300,000
Change %: -2.7%
Price
Shares after: 10,909,723
Date: 11 Sep 2026
Ownership: See Footnotes
Underlying class: Class B Shares
Underlying amount: 300,000
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported transaction represents a gift/charitable donation of securities indirectly owned through Dyal Capital SLP LP ("Dyal SLP") that were distributed to the reporting person and donated to National Philanthropic Trust, a Pennsylvania non-profit corporation, to be held in a donor-advised fund.

Footnote F2

Consists of an aggregate of 10,909,723 shares of Class D common stock ("Class D Shares") and an equal number of common units ("Blue Owl Operating Group Units") of Blue Owl Capital Holdings LP, a Delaware limited partnership ("Blue Owl Holdings"), associated with such Class D Shares, held directly by Dyal SLP, on behalf of Mr. Rees, his spouse and one or more entities controlled by him. Mr. Rees expressly disclaims beneficial ownership of the securities held by Dyal SLP except to the extent of his pecuniary interest therein.

Footnote F3

Each Blue Owl Operating Group Unit, upon the cancellation of an equal number of Class D Shares, may be exchanged from time to time for an equal number of newly issued shares of Class B common stock ("Class B Shares"), subject to any applicable transfer restrictions and the terms of the Third Amended and Restated Exchange Agreement, dated as of April 1, 2025, or (at the election of an exchange committee of the general partner of Blue Owl Holdings) a cash payment equal to the five-day volume weighted average price of shares of Class A common stock immediately prior to the applicable exchange date. Blue Owl Operating Group Units do not expire.

SEC remarks

The reported amounts do not include Blue Owl Operating Group Units associated with the Issuer's Class C common stock beneficially owned by the reporting person, as they represent a different class of security from the Blue Owl Operating Group Units associated with the Issuer's Class D Shares reported in this statement.